NCT02413528

Brief Summary

The purpose of this study is to assess the use of a mobile health intervention to improve adherence to asthma medication among adolescents. The intervention consists of an inhaler sensor strap to monitor asthma inhaler use and a mobile phone application to remind and incentivize patients to use their medication. This study will assess medication use throughout the study in patients who receive a mobile app with reminders and asthma control as measured by the ACT \[asthma control test\].

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable asthma

Timeline
Completed

Started Oct 2014

Shorter than P25 for not_applicable asthma

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

April 7, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 10, 2015

Completed
Last Updated

August 4, 2016

Status Verified

August 1, 2016

Enrollment Period

5 months

First QC Date

April 7, 2015

Last Update Submit

August 3, 2016

Conditions

Keywords

Patient ComplianceMobile Applications

Outcome Measures

Primary Outcomes (1)

  • Real-time medication adherence in patients receiving reminders and incentives compared to standard care.

    Analysis of real-time medication use data in the experimental \[app + sensor\] arm vs the sensor only arm.

    12 weeks

Secondary Outcomes (1)

  • Asthma control in patients receiving reminders and incentives compared to standard care (Analysis of the ACT [asthma control test])

    12 weeks

Study Arms (2)

Standard Care with Medication Monitoring

SHAM COMPARATOR

Patients will be given an inhaler sensor to monitor medication use and a sham version of the mobile app that will not include reminders or incentives. Intervention: Inhaler sensor

Device: Inhaler sensor

Medication Monitoring and Mobile App

EXPERIMENTAL

Patients will be given an inhaler sensor to monitor medication use and a mobile phone application that will send them reminders and provide an opportunity to see their own medication use and win incentives for adherence. Interventions: Inhaler sensor and mobile application for asthma adherence

Device: Inhaler sensorBehavioral: Mobile application for asthma adherence

Interventions

Inhaler sensor strap that tracks inhaler use via a pressure sensitive switch.

Medication Monitoring and Mobile AppStandard Care with Medication Monitoring

Mobile phone application that sends reminders, allows patients to see their medication use, and provides points and other incentives for medication use.

Medication Monitoring and Mobile App

Eligibility Criteria

Age11 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 11-19
  • Asthma diagnosis
  • Currently on a daily controller HFA (hydrofluoroalkane) medication for Asthma
  • English-speaking
  • Has a smartphone or access to a smartphone or tablet

You may not qualify if:

  • Pregnant
  • Foster Care
  • Emancipated minor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AsthmaPatient Compliance

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Andrew M Ting, MD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR
  • Michael M Parides, PhD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2015

First Posted

April 10, 2015

Study Start

October 1, 2014

Primary Completion

March 1, 2015

Study Completion

April 1, 2015

Last Updated

August 4, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share